This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

DaVita HealthCare Partners Inc
DVA : NYSE : Health Care

$69.51 | %
Today's Range: 68.70 - 69.96
Avg. Daily Volume: 1,577,700
04/17/14 - 4:01 PM ET

Financial Analysis


DAVITA HEALTHCARE PARTNERS's gross profit margin for the fourth quarter of its fiscal year 2013 is essentially unchanged when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. DAVITA HEALTHCARE PARTNERS has average liquidity. Currently, the Quick Ratio is 1.13 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year, indicating improving cash flow.

During the same period, stockholders' equity ("net worth") has increased by 17.78% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q4 FY13 Q4 FY12
Net Sales ($mil)3063.212477.85
EBITDA ($mil)615.33508.8
EBIT ($mil)475.86399.52
Net Income ($mil)212.28155.84


Balance Sheet Q4 FY13 Q4 FY12
Cash & Equiv. ($mil)953.05540.89
Total Assets ($mil)17098.8816018.6
Total Debt ($mil)8415.938554.33
Equity ($mil)4432.483763.14


Profitability Q4 FY13 Q4 FY12
Gross Profit Margin30.5431.09
EBITDA Margin20.0820.53
Operating Margin15.5316.12
Sales Turnover0.690.51
Return on Assets3.73.34
Return on Equity13.9914.24
Debt Q4 FY13 Q4 FY12
Current Ratio1.411.43
Debt/Capital0.660.69
Interest Expense109.4299.43
Interest Coverage4.354.02


Share Data Q4 FY13 Q4 FY12
Shares outstanding (mil)213.16211.0
Div / share0.00.0
EPS0.990.76
Book value / share20.7917.83
Institutional Own % n/a n/a
Avg Daily Volume1585656.02063601.0

Valuation


BUY. The current P/E ratio indicates a discount compared to an average of 32.04 for the Health Care Providers & Services industry and a premium compared to the S&P 500 average of 18.29. For additional comparison, its price-to-book ratio of 3.27 indicates a premium versus the S&P 500 average of 2.52 and a premium versus the industry average of 2.93. The current price-to-sales ratio is below the S&P 500 average, but above the industry average.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
DVA 23.47 Peers 32.04   DVA 8.17 Peers 29.31

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

DVA is trading at a significant discount to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

DVA is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
DVA 17.29 Peers 18.35   DVA 0.84 Peers 4.65

Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.

DVA is trading at a valuation on par with its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

DVA trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
DVA 3.27 Peers 2.93   DVA 6.23 Peers 197.25

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

DVA is trading at a premium to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, DVA is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
DVA 1.23 Peers 0.76   DVA 43.70 Peers 11.70

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

DVA is trading at a significant premium to its industry.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

DVA has a sales growth rate that significantly exceeds its peers.

 

 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs